{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:43:45Z","timestamp":1792806225161,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100008721","name":"University College London Hospitals NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007472","name":"University of Kentucky","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007472","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bjanaesthesia.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.bja.2019.05.026","type":"journal-article","created":{"date-parts":[[2019,6,15]],"date-time":"2019-06-15T02:08:53Z","timestamp":1560564533000},"page":"e385-e396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["A systematic review of rescue analgesic strategies in acute exacerbations of primary trigeminal neuralgia"],"prefix":"10.1016","volume":"123","author":[{"given":"D.","family":"Moore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.S.","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Zakrzewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bja.2019.05.026_bib1","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S1474-4422(18)30085-1","article-title":"International classification of headache Disorders","volume":"17","author":"Olesen","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.bja.2019.05.026_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.0000000000002840","article-title":"Trigeminal neuralgia: new classification and diagnostic grading for practice and research","volume":"87","author":"Cruccu","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.bja.2019.05.026_bib3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2296-9-26","article-title":"Primary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002\u20132005","volume":"9","author":"Hall","year":"2008","journal-title":"BMC Fam Pract"},{"key":"10.1016\/j.bja.2019.05.026_bib4","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.pain.2009.08.023","article-title":"Incidence of facial pain in the general population","volume":"147","author":"Koopman","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.bja.2019.05.026_bib5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1129-2377-15-34","article-title":"Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary centre for neuropathic pain","volume":"15","author":"Di Stefano","year":"2014","journal-title":"J\u00a0Headache Pain"},{"key":"10.1016\/j.bja.2019.05.026_bib6","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1111\/head.12441","article-title":"Trigeminal neuralgia--a prospective systematic study of clinical characteristics in 158 patients","volume":"54","author":"Maarbjerg","year":"2014","journal-title":"Headache"},{"key":"10.1016\/j.bja.2019.05.026_bib7","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1097\/j.pain.0000000000000853","article-title":"Evaluating the impact of trigeminal neuralgia","volume":"158","author":"Zakrzewska","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.bja.2019.05.026_bib8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1533-2500.2006.00079.x","article-title":"Patient burden of trigeminal neuralgia: results from a cross-sectional survey of health state impairment and treatment patterns in six European countries","volume":"6","author":"Tolle","year":"2006","journal-title":"Pain Pract"},{"key":"10.1016\/j.bja.2019.05.026_bib9","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1468-1331.2008.02185.x","article-title":"AAN-EFNS guidelines on trigeminal neuralgia management","volume":"15","author":"Cruccu","year":"2008","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.bja.2019.05.026_bib10","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/AJP.0000000000000595","article-title":"Characterizing treatment utilization patterns for trigeminal neuralgia in the United States","volume":"34","author":"Zakrzewska","year":"2018","journal-title":"Clin J Pain"},{"key":"10.1016\/j.bja.2019.05.026_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.bja.2019.05.026_bib12","series-title":"Classification of chronic pain. Descriptors of chronic pain syndromes and definitions of pain terms","author":"Merskey","year":"1994"},{"key":"10.1016\/j.bja.2019.05.026_bib13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1212\/01.wnl.0000342200.58823.6a","article-title":"Levels of evidence: taking neurology to the next level","volume":"72","author":"Gross","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.bja.2019.05.026_bib14","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.bja.2019.05.026_bib15","doi-asserted-by":"crossref","first-page":"i2089","DOI":"10.1136\/bmj.i2089","article-title":"GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: clinical practice guidelines","volume":"353","author":"Alonso-Coello","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.bja.2019.05.026_bib16","first-page":"159","article-title":"Treatment of trigeminal neuralgia by ophthalmic anesthetic","volume":"77","author":"Spaziante","year":"1992","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.bja.2019.05.026_bib17","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1001\/jama.1991.03460210053014","article-title":"Trigeminal neuralgia relieved by ophthalmic anesthetic","volume":"265","author":"Zavon","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.bja.2019.05.026_bib18","first-page":"993","article-title":"The effect of single-application topical ophthalmic anesthesia in patients with trigeminal neuralgia. A randomized double-blind placebo-controlled trial","volume":"80","author":"Kondziolka","year":"1994","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.bja.2019.05.026_bib19","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/bja\/ael180","article-title":"Intranasal lidocaine 8% spray for second-division trigeminal neuralgia","volume":"97","author":"Kanai","year":"2006","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2019.05.026_bib20","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/pme.12349","article-title":"Immediate analgesic effect of 8% lidocaine applied to the oral mucosa in patients with trigeminal neuralgia","volume":"15","author":"Niki","year":"2014","journal-title":"Pain Med"},{"key":"10.1016\/j.bja.2019.05.026_bib21","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1212\/WNL.43.6.1233","article-title":"Response to intravenous lidocaine infusion differs based on clinical diagnosis and site of nervous system injury","volume":"43","author":"Galer","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.bja.2019.05.026_bib22","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1111\/head.12401","article-title":"Intravenous lidocaine treatment in classical trigeminal neuralgia with concomitant persistent facial pain","volume":"54","author":"Chaudhry","year":"2014","journal-title":"Headache"},{"key":"10.1016\/j.bja.2019.05.026_bib23","doi-asserted-by":"crossref","first-page":"853826","DOI":"10.1155\/2014\/853826","article-title":"The effect of intravenous lidocaine on trigeminal neuralgia: a randomized double blind placebo controlled trial","volume":"2014","author":"Stavropoulou","year":"2014","journal-title":"ISRN Pain"},{"key":"10.1016\/j.bja.2019.05.026_bib24","first-page":"19","article-title":"Effects of oral carbamazepine with 2% lidocaine on maxillary and mandibular nerve blocks in trigeminal neuralgia","volume":"12","author":"Baykal","year":"2010","journal-title":"Duzce Med J"},{"key":"10.1016\/j.bja.2019.05.026_bib25","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jclinane.2014.03.011","article-title":"Novel treatment in refractory tic douloureux","volume":"26","author":"Soleimanpour","year":"2014","journal-title":"J\u00a0Clin Anesth"},{"key":"10.1016\/j.bja.2019.05.026_bib26","first-page":"960","article-title":"Intravenous lidocaine and magnesium for management of intractable trigeminal neuralgia: a case series of nine patients","volume":"27","author":"Arai","year":"2013","journal-title":"J\u00a0Anesth"},{"key":"10.1016\/j.bja.2019.05.026_bib27","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.2146\/ajhp100636","article-title":"Treatment of refractory trigeminal neuralgia with intravenous phenytoin","volume":"68","author":"Tate","year":"2011","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.bja.2019.05.026_bib28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/1756285615583202","article-title":"Intravenous fosphenytoin for acute exacerbation of trigeminal neuralgia: case report and literature review","volume":"8","author":"Vargas","year":"2015","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.bja.2019.05.026_bib29","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0885-3924(01)00269-X","article-title":"Fosphenytoin: an intravenous option for the management of acute trigeminal neuralgia crisis","volume":"21","author":"Cheshire","year":"2001","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.bja.2019.05.026_bib30","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1526-4610.2006.00405.x","article-title":"Subcutaneous sumatriptan for refractory trigeminal neuralgia","volume":"46","author":"Kanai","year":"2006","journal-title":"Headache"},{"key":"10.1016\/j.bja.2019.05.026_bib31","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1526-4610.2006.00405.x","article-title":"Subcutaneous sumatriptan for refractory trigeminal neuralgia","volume":"46","author":"Kanai","year":"2006","journal-title":"Headache"},{"key":"10.1016\/j.bja.2019.05.026_bib32","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/01.ajp.0000210917.18536.0d","article-title":"Sumatriptan alleviates pain in patients with trigeminal neuralgia","volume":"22","author":"Kanai","year":"2006","journal-title":"Clin J Pain"},{"key":"10.1016\/j.bja.2019.05.026_bib33","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1526-4610.2008.01254.x","article-title":"Nasal sumatriptan as adjunctive therapy for idiopathic trigeminal neuralgia: report of three cases","volume":"49","author":"Shimohata","year":"2009","journal-title":"Headache"},{"key":"10.1016\/j.bja.2019.05.026_bib34","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1590\/S0004-282X2008000400012","article-title":"Beneficial effects of botulinum toxin type A in trigeminal neuralgia","volume":"66","author":"Zuniga","year":"2008","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.bja.2019.05.026_bib35","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/WNF.0b013e31829cb60e","article-title":"Acute treatment of trigeminal neuralgia with onabotulinum toxin A","volume":"36","author":"Z\u00fa\u00f1iga","year":"2013","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.bja.2019.05.026_bib36","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/00002508-200201000-00002","article-title":"Pathophysiology of trigeminal neuralgia: the ignition hypothesis","volume":"18","author":"Devor","year":"2002","journal-title":"Clin J Pain"},{"key":"10.1016\/j.bja.2019.05.026_bib37","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0304-3959(85)90006-5","article-title":"The systemic administration of local anaesthetics produces a selective depression of C-afferent fibre evoked activity in the spinal cord","volume":"23","author":"Woolf","year":"1985","journal-title":"Pain"},{"key":"10.1016\/j.bja.2019.05.026_bib38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0304-3959(95)00072-0","volume":"64","author":"Nagy","year":"1996","journal-title":"Pain"},{"key":"10.1016\/j.bja.2019.05.026_bib39","first-page":"Cd003345","article-title":"Systemic administration of local anesthetic agents to relieve neuropathic pain","volume":"4","author":"Challapalli","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bja.2019.05.026_bib40","article-title":"Sensitivity of the DN4 in screening for neuropathic pain syndromes","author":"VanDenKerkhof","year":"2017","journal-title":"Clin J Pain"},{"key":"10.1016\/j.bja.2019.05.026_bib41","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1468-2982.2004.00886.x","article-title":"SUNCT syndrome responsive to intravenous lidocaine","volume":"24","author":"Matharu","year":"2004","journal-title":"Cephalalgia"},{"key":"10.1016\/j.bja.2019.05.026_bib42","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jcms.2011.03.022","article-title":"Treatment of trigeminal neuralgia with bupivacaine HCL using a temporary epidural catheter and pain pump: preliminary study","volume":"40","author":"Dergin","year":"2012","journal-title":"J\u00a0Craniomaxillofac Surg"},{"key":"10.1016\/j.bja.2019.05.026_bib43","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/AJP.0b013e318158011a","article-title":"Gabapentin supplemented with ropivacain block of trigger points improves pain control and quality of life in trigeminal neuralgia patients when compared with gabapentin alone","volume":"24","author":"Lemos","year":"2008","journal-title":"Clin J Pain"},{"key":"10.1016\/j.bja.2019.05.026_bib44","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S1010-5182(05)80423-8","article-title":"Peripheral streptomycin\/lidocaine injections versus lidocaine alone in the treatment of idiopathic trigeminal neuralgia. A double blind controlled trial","volume":"18","author":"Stajcic","year":"1990","journal-title":"J\u00a0Craniomaxillofac Surg"},{"key":"10.1016\/j.bja.2019.05.026_bib45","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1526-4610.1993.hed3303155.x","article-title":"The effects of streptomycin\/lidocaine block on trigeminal neuralgia: a double blind crossover placebo controlled study","volume":"33","author":"Bittar","year":"1993","journal-title":"Headache"},{"key":"10.1016\/j.bja.2019.05.026_bib46","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1742-1241.2007.01568.x","article-title":"Efficacy and safety of high concentration lidocaine for trigeminal nerve block in patients with trigeminal neuralgia","volume":"62","author":"Han","year":"2008","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.bja.2019.05.026_bib47","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0304-3959(98)00156-0","article-title":"The long lasting effects of peripheral nerve blocks for trigeminal neuralgia using high concentration of tetracaine dissolved in bupivacaine","volume":"79","author":"Goto","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.bja.2019.05.026_bib48","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/00002508-200112000-00006","article-title":"High-concentration tetracaine for the management of trigeminal neuralgia: quantitative assessment of sensory function after peripheral nerve block","volume":"17","author":"Radwan","year":"2001","journal-title":"Clin J Pain"},{"key":"10.1016\/j.bja.2019.05.026_bib49","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0304-3959(91)90100-C","article-title":"The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states","volume":"44","author":"Woolf","year":"1991","journal-title":"Pain"},{"key":"10.1016\/j.bja.2019.05.026_bib50","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/anae.12107","article-title":"A\u00a0double-blinded randomised controlled study of the value of sequential intravenous and oral magnesium therapy in patients with chronic low back pain with a neuropathic component","volume":"68","author":"Yousef","year":"2013","journal-title":"Anaesthesia"},{"key":"10.1016\/j.bja.2019.05.026_bib51","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/bja\/89.5.711","article-title":"Efficacy of intravenous magnesium in neuropathic pain","volume":"89","author":"Brill","year":"2002","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2019.05.026_bib52","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0304-3959(94)00170-J","article-title":"Effect of ketamine, an NMDA receptor inhibitor, in acute and chronic orofacial pain","volume":"61","author":"Mathisen","year":"1995","journal-title":"Pain"},{"key":"10.1016\/j.bja.2019.05.026_bib53","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1212\/WNL.55.7.964","article-title":"A\u00a0randomized, controlled trial of high-dose dextromethorphan in facial neuralgias","volume":"55","author":"Gilron","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.bja.2019.05.026_bib54","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00002508-200201000-00004","article-title":"Pharmacotherapy of trigeminal neuralgia","volume":"18","author":"Sindrup","year":"2002","journal-title":"Clin J Pain"},{"issue":"9 Pt 1","key":"10.1016\/j.bja.2019.05.026_bib55","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1212\/WNL.28.9.874","article-title":"Intravenous phenytoin: clinical and pharmacokinetic aspects","volume":"28","author":"Cranford","year":"1978","journal-title":"Neurology"},{"key":"10.1016\/j.bja.2019.05.026_bib56","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/j.1875-9114.1996.tb02996.x","article-title":"Fosphenytoin: a novel phenytoin prodrug","volume":"16","author":"Boucher","year":"1996","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.bja.2019.05.026_bib57","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000116756","article-title":"The clinical pharmacology, pharmacokinetics and metabolism of sumatriptan","volume":"31","author":"Fowler","year":"1991","journal-title":"Eur Neurol"},{"key":"10.1016\/j.bja.2019.05.026_bib58","first-page":"Cd009108","article-title":"Sumatriptan (all routes of administration) for acute migraine attacks in adults - overview of Cochrane reviews","volume":"5","author":"Derry","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bja.2019.05.026_bib59","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.410230214","article-title":"Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system","volume":"23","author":"Goadsby","year":"1988","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bja.2019.05.026_bib60","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0035-3787(05)85120-3","article-title":"Trigeminal autonomic cephalalgias. Pathophysiology and classification","volume":"161","author":"Goadsby","year":"2005","journal-title":"Rev Neurol"},{"key":"10.1016\/j.bja.2019.05.026_bib61","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0304-3959(00)00475-9","article-title":"An in\u00a0vivo rat model to study calcitonin gene related peptide release following activation of the trigeminal vascular system","volume":"92","author":"Limmroth","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.bja.2019.05.026_bib62","unstructured":"(2012) NIfHaCE. Botulinum toxin type A for the prevention of headaches in adults with chronic migraine. NICE Technology appraisal guidance [TA260]."},{"key":"10.1016\/j.bja.2019.05.026_bib63","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1212\/WNL.0000000000002560","article-title":"Practice guideline update summary: botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: report of the Guideline Development Subcommittee of the American Academy of Neurology","volume":"86","author":"Simpson","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.bja.2019.05.026_bib64","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.medcli.2016.07.032","article-title":"Botulinum toxin in trigeminal neuralgia","volume":"148","author":"Castillo-Alvarez","year":"2017","journal-title":"Medicina Clinica"},{"key":"10.1016\/j.bja.2019.05.026_bib65","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.parkreldis.2011.06.013","article-title":"Updates on the antinociceptive mechanism hypothesis of botulinum toxin A","volume":"17","author":"Aoki","year":"2011","journal-title":"Parkinsonism Related Disord"},{"key":"10.1016\/j.bja.2019.05.026_bib66","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/bja\/aet125","article-title":"Differential diagnosis of facial pain and guidelines for management","volume":"111","author":"Zakrzewska","year":"2013","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2019.05.026_bib67","doi-asserted-by":"crossref","first-page":"g474","DOI":"10.1136\/bmj.g474","article-title":"Trigeminal neuralgia","volume":"348","author":"Zakrzewska","year":"2014","journal-title":"BMJ"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091219304301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091219304301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T17:14:45Z","timestamp":1762103685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007091219304301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0007091219304301"],"URL":"https:\/\/doi.org\/10.1016\/j.bja.2019.05.026","relation":{},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review of rescue analgesic strategies in acute exacerbations of primary trigeminal neuralgia","name":"articletitle","label":"Article Title"},{"value":"British Journal of Anaesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bja.2019.05.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 British Journal of Anaesthesia. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}